Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Minimal Residual Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT05603156
What this trial is testing

Olverembatinib Combined With Inotuzumab Ozogamicin in the Treatment ph+ ALL With MRD Persistent Positive

Who this might be right for
Ph+ ALLBone Marrow TransplantMinimal Residual Disease
Institute of Hematology & Blood Diseases Hospital, China 46
Not applicableLooking for participantsNCT05433753
What this trial is testing

Asian Multicenter Prospective Study in HER2 Positive Early Breast Cancer for Detecting MRD by ctDNA;HARMONY Study

Who this might be right for
HER2-positive Breast Cancer
National Cancer Center, Japan 60
Large-scale testing (Phase 3)Enrolling By InvitationNCT07537257
What this trial is testing

VEN+IDAC vs IDAC in AML

Who this might be right for
AML (Acute Myelogenous Leukemia)
Guangdong Second Provincial General Hospital 232
Testing effectiveness (Phase 2)Looking for participantsNCT05940961
What this trial is testing

Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL

Who this might be right for
ALLMRD-positiveHematopoietic Stem Cell Transplantation
Sheng-Li Xue, MD 42
Early research (Phase 1)WithdrawnNCT06522373
What this trial is testing

Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease

Who this might be right for
Leukemia
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT04944173
What this trial is testing

SCION: SABR and Checkpoint Inhibition of NSCLC

Who this might be right for
Non Small Cell Lung CancerCarcinoma, Non-Small-Cell LungNon-small Cell Lung Cancer Stage I+4 more
University of British Columbia
Not applicableActive Not RecruitingNCT05210283
What this trial is testing

CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Exact Sciences Corporation 1,017
Not applicableUnknownNCT03413046
What this trial is testing

The Effect of Chemotherapy on Regulatory T Cells

Who this might be right for
Pre B ALLRegulatory T Cell
Ankara Children's Health and Diseases Hematology and Oncology Training and Research Hospital 60
Early research (Phase 1)WithdrawnNCT05720988
What this trial is testing

Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Jonsson Comprehensive Cancer Center
Not applicableNot Yet RecruitingNCT07350824
What this trial is testing

Predictive Value of Minimal Residual Disease for Postoperative Recurrence and Adjuvant PD-1 Inhibitor in HCC

Who this might be right for
HCCMinimal Residual DiseaseRecurrence
Tongji Hospital 276
Not applicableStudy completedNCT00819143
What this trial is testing

Collection of Blood and Bone Marrow Samples From Select Patients With CML to Measure Minimal Residual Disease

Who this might be right for
Leukemia
National Heart, Lung, and Blood Institute (NHLBI) 3
Not applicableEnrolling By InvitationNCT06102889
What this trial is testing

GUIDING MULTI-MODAL THERAPIES AGAINST MINIMAL RESIDUAL DISEASE BY LIQUID BIOPSIES

Who this might be right for
Pancreatic Adenocarcinoma
Karolinska University Hospital 200
Not applicableUnknownNCT02400970
What this trial is testing

Contamination of Testicle Tissue by RT-PCR in Participants With Solid Tumors

Who this might be right for
Minimal Residual DiseaseFertility Preservation
University Hospital, Clermont-Ferrand 40
Not applicableUnknownNCT05697913
What this trial is testing

Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation

Who this might be right for
Multiple Myeloma
Hospital Galdakao-Usansolo 66
Large-scale testing (Phase 3)Looking for participantsNCT05929222
What this trial is testing

Comparison Between Local Radiotherapy Alone or Combined With Obinutuzumab in Early Stage Follicular Lymphoma: the GAZEBO Trial From the Fondazione Italiana Linfomi

Who this might be right for
Follicular Lymphoma
Fondazione Italiana Linfomi - ETS 190
Early research (Phase 1)Ended earlyNCT05001451
What this trial is testing

Study of GDX012 in Patients With MRD Positive AML

Who this might be right for
Acute Myeloid Leukemia
GammaDelta Therapeutics Limited 3
Testing effectiveness (Phase 2)Looking for participantsNCT05343013
What this trial is testing

TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 25
Not applicableUnknownNCT05426850
What this trial is testing

CtDNA-based MRD Assessment in Local Advanced Esophageal Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 100
Testing effectiveness (Phase 2)Ended earlyNCT02349178
What this trial is testing

Bridging Study to Eliminate Presence of MRD for Acute Leukemia Before HCT

Who this might be right for
Leukemia, Acute LymphoblasticAcute Myeloid Leukemia
Medical College of Wisconsin 6
Testing effectiveness (Phase 2)Looking for participantsNCT05872724
What this trial is testing

Optimization of Postoperative Adjuvant Therapy for Cervical Cancer Based on MRD(Minimal Residual Disease)

Who this might be right for
Cervical Cancer
Suzhou Municipal Hospital 32
Next Page